InsiderTrades

Form 4 for PGNY Progyny, Inc.

Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-01 · accession 0001551306-24-000009 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-05 2024-02-01 PGNY Livingston Mark S. CFO M - OptEx $3.95 +22.0K 68.9K +47% +$86.9K
D 2024-02-05 2024-02-01 PGNY Livingston Mark S. CFO F - Tax $38.10 -12.3K 56.5K -18% -$470.5K
DM 2024-02-05 2024-02-01 PGNY Livingston Mark S. CFO S - Sale+OE $37.84 -12.7K 43.9K -22% -$478.8K
D 2024-02-05 2024-02-01 PGNY Livingston Mark S. CFO M - OptEx $0.00 -22.0K 42.6K -34% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-01 M A 22,000 $3.95 68,871 D — —
2 Common Common Stock 2024-02-01 F D 12,349 $38.10 56,522 D — —
3 Common Common Stock 2024-02-01 S D 9,651 $37.83 46,871 D — —
4 Common Common Stock 2024-02-01 S D 3,000 $37.89 43,871 D — —
5 Derivative Stock Option (Right to Buy) 2024-02-01 M D 22,000 $0.00 42,627 D $3.95 · — to 2029-06-03 22,000 Common Stock (F2) These options are fully vested and exercisable.